CSF2 and acute myeloid leukemia: The basal advantage in median G-CSF and GM-CSF production by AML vs. BCP-ALL blasts was also maintained after PHA and LPS stimulation and after PMA + I stimulation for GM-CSF only (Table 1, Figure 2).